Jinhua®Jintiange Capsule

Description‌：
Jintiange Capsule is a proprietary Chinese patent medicine with the national drug approval number Z20030080. Its only active ingredient is artificial tiger bone powder. The capsule contains off-white or light yellow powder, with a slight odor and tasteless. It belongs to Class B of China’s National Medical Insurance Catalogue, and is developed and produced by Xi’an Jinhua Pharmaceutical Factory of Jinhua Enterprise (Group) Co., Ltd.

Indications‌：
It has the bone-strengthening effect, used to improve symptoms such as low back pain, soreness and weakness of waist and knees, flaccidity of lower limbs, and difficulty in walking. Clinically, it is often used for adjuvant treatment of senile osteoporosis, degenerative osteoarthropathy and other bone metabolic related diseases.

Dosage and Administration‌：
Administration‌: Oral administration, swallow the capsules whole with warm water, do not chew or break the contents.
Dosage‌: Take 3 capsules each time, 3 times a day. One box of 36 capsules can be taken for about 3 days, and the standard treatment course is 3 months.

Precautions‌：
Drink plenty of water during the medication period. If you are taking other drugs at the same time, you must consult a doctor or pharmacist before use to avoid potential interactions. If the appearance and properties of the capsule change, stop taking it immediately.

Contraindications‌：
The official approved instructions have not clearly specified absolute contraindications. It is forbidden for people who are allergic to any component of this product. Patients with yin deficiency and fire excess should use it with caution.

Adverse Reactions‌：
No obvious severe adverse reactions have been found in clinical trials. Occasionally, individual patients will experience mild dry mouth after taking the medicine, which can be relieved by drinking more water and usually does not require special intervention.

Drug Interactions‌：
No clinically significant obvious adverse interactions with common combined medications have been found in existing clinical data.

Special Populations‌：
Pregnant and lactating women: It is not recommended to use it, and must be strictly evaluated and guided by a doctor before deciding whether to take it.
Children: There is a lack of sufficient safety data for this population, and it is not recommended to use it without medical advice.
Elderly patients: It can be used conventionally according to the recommended dosage, and no special dose adjustment is required under normal liver and kidney function.